Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 14, 2003

View Archived Issues

XenoPort and Alza combine technologies in collaboration

Evotec and Oxagen enter drug discovery alliance

Cephalon and MDS Proteomics enter drug discovery research collaboration

Peregrine and Schering collaborate to develop vascular targeting agents

Several series of delta opioid receptor agonists prepared and tested at AstraZeneca

Novel inhibitors of VLA-4-mediated cell adhesion described in recent patent

Sumitomo patents series of antidiabetic piperazines

Pyrrole-based agents for epilepsy and neuropathic pain identified at Ortho-McNeil

Novel apoptosis inhibitors with utility in cancer and other disorders

Senju researchers describe novel antibacterial PDF inhibitors

Bicyclic factor Xa inhibitors designed by BMS scientists

Possible treatment for IgA nephropathy being developed by CuraGen and Abgenix

Inspire prepares to submit NDA for diquafosol by mid-2003

AME-359 protects rats from cocaine overdose

Safinamide plus dopamine agonist therapy improves motor scores in PD

Chiron partners with GlaxoSmithKline for obesity program

Purdue licenses Corixa antigen

Canadian phase I trial of Infecton imaging agent cleared to begin

Phase I/II results announced for Genzyme Molecular Oncology's melanoma vaccine

Senexis receives start-up funding from BTG and Catalyst BioMedica

Celltech relaunches Dipentum

Human Genome Sciences updates pipeline progress

BAL-9141: potency and spectrum of activity tested against large number of clinical isolates

Safety of WHI-05 and WHI-07 demonstrated preclinically

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...